The plasticity of human Treg and Th17 cells and its role in autoimmunity

Seminars in Immunology

Volumn 25, Issue 4, 2013, Pages 305-312

  Kleinewietfeld, Markus ^a,b   Hafler, David A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

Autoimmunity; CD4+ T cells; FoxP3; IL 17; T cell plasticity; Th17; Treg

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CD147 ANTIGEN; CD161 ANTIGEN; CD31 ANTIGEN; CD39 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR6; FAS ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; MYELIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VERY LATE ACTIVATION ANTIGEN 4;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; BACTEROIDES FRAGILIS; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; GAIN OF FUNCTION MUTATION; HELMINTHIASIS; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; IPEX SYNDROME; MUCOCUTANEOUS CANDIDIASIS; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NERVE FIBER; NONHUMAN; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL; WHITE MATTER;

AUTOIMMUNITY; CD4(+) T CELLS; FOXP3; IL-17; T CELL PLASTICITY; TH17; TREG;

ANIMALS; AUTOIMMUNITY; CELL COMMUNICATION; HUMANS; MULTIPLE SCLEROSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84888871863     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.10.009     Document Type: Review

References (150)

1. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annual Review of Immunology 2009, 27:485-517.
2. Vahedi G., Poholek C.A., Hand T.W., Laurence A., Kanno Y., O'Shea J.J., et al. Helper T-cell identity and evolution of differential transcriptomes and epigenomes. Immunological Reviews 2013, 252:24-40.
3. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
4. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunology 2005, 6:1133-1141.
5. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunology 2005, 6:1123-1132.
6. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
7. Bettelli E., Korn T., Kuchroo V.K. Th17: the third member of the effector T cell trilogy. Current Opinion in Immunology 2007, 19:652-657.
8. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nature Reviews Immunology 2008, 8:337-348.
9. Schraml B.U., Hildner K., Ise W., Lee W.L., Smith W.A., Solomon B., et al. The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature 2009, 460:405-409.
10. Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H.S., Chung Y., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008, 28:29-39.
11. Huber M., Brustle A., Reinhard K., Guralnik A., Walter G., Mahiny A., et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:20846-20851.
12. Chung Y., Chang S.H., Martinez G.J., Yang X.O., Nurieva R., Kang H.S., et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009, 30:576-587.
13. Ciofani M., Madar A., Galan C., Sellars M., Mace K., Pauli F., et al. A validated regulatory network for Th17 cell specification. Cell 2012, 151:289-303.
14. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of T(H)17 cells. Nature 2008, 453:1051-1057.
15. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nature Immunology 2007, 8:950-957.
16. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto F. Interleukins 1[beta] and 6 but not transforming growth factor-[beta] are essential for the differentiation of interleukin 17-producing human T helper cells. Nature Immunology 2007, 8:942-949.
17. Yang L., Anderson D.E., Baecher-Allan C., Hastings W.D., Bettelli E., Oukka M., et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008, 454:350-352.
18. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
19. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. Journal of Experimental Medicine 2005, 201:233-240.
20. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nature Immunology 2007, 8:639-646.
21. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., et al. Phenotypic and functional features of human Th17 cells. Journal of Experimental Medicine 2007, 204:1849-1861.
22. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. Journal of Experimental Medicine 2007, 204:2803-2812.
23. Annunziato F., Cosmi L., Liotta F., Maggi E., Romagnani S. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. International Immunology 2008, 20:1361-1368.
24. Kleinewietfeld M., Starke M., Di Mitri D., Borsellino G., Battistini L., Rotzschke O., et al. CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells. Blood 2009, 113:827-836.
25. Brucklacher-Waldert V., Steinbach K., Lioznov M., Kolster M., Holscher C., Tolosa E. Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression. Journal of Immunology 2009, 183:5494-5501.
26. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
27. Pappu R., Rutz S., Ouyang W. Regulation of epithelial immunity by IL-17 family cytokines. Trends in Immunology 2012, 33:343-349.
28. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
29. Iwakura Y., Ishigame H., Saijo S., Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011, 34:149-162.
30. Puel A., Cypowyj S., Marodi L., Abel L., Picard C., Casanova J.L. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Current Opinion in Allergy and Clinical Immunology 2012, 12:616-622.
31. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
32. Ma C.S., Chew G.Y., Simpson N., Priyadarshi A., Wong M., Grimbacher B., et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. Journal of Experimental Medicine 2008, 205:1551-1557.
33. Liu L., Okada S., Kong X.F., Kreins A.Y., Cypowyj S., Abhyankar A., et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. Journal of Experimental Medicine 2011, 208:1635-1648.
34. van de Veerdonk F.L., Plantinga T.S., Hoischen A., Smeekens S.P., Joosten L.A., Gilissen C., et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. New England Journal of Medicine 2011, 365:54-61.
35. Nylander A., Hafler D.A. Multiple sclerosis. Journal of Clinical Investigation 2012, 122:1180-1188.
36. Greer J.M., Pender M.P. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis. Journal of Autoimmunity 2008, 31:281-287.
37. Raddassi K., Kent S.C., Yang J., Bourcier K., Bradshaw E.M., Seyfert-Margolis V., et al. Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis. Journal of Immunology 2011, 187:1039-1046.
38. Codarri L., Gyulveszi G., Tosevski V., Hesske L., Fontana A., Magnenat L., et al. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nature Immunology 2011, 12:560-567.
39. El-Behi M., Ciric B., Dai H., Yan Y., Cullimore M., Safavi F., et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nature Immunology 2011, 12:568-575.
40. Matusevicius D., Kivisakk P., He B., Kostulas N., Ozenci V., Fredrikson S., et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Multiple Sclerosis 1999, 5:101-104.
41. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nature Medicine 2007, 13:1173-1175.
42. Han M.H., Hwang S.I., Roy D.B., Lundgren D.H., Price J.V., Ousman S.S., et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 2008, 451:1076-1081.
43. Brucklacher-Waldert V., Stuerner K., Kolster M., Wolthausen J., Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain: A Journal of Neurology 2009, 132:3329-3341.
44. Li Y., Wang H., Long Y., Lu Z., Hu X. Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis. Journal of Neuroimmunology 2011, 234:155-160.
45. Tesmer L.A., Lundy S.K., Sarkar S., Fox D.A. Th17 cells in human disease. Immunological Reviews 2008, 223:87-113.
46. Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nature Immunology 2009, 10:514-523.
47. Zepp J., Wu L., Li X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends in Immunology 2011, 32:232-239.
48. Littman D.R., Rudensky A.Y. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 2010, 140:845-858.
49. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nature Reviews Immunology 2009, 9:313-323.
50. Atarashi K., Nishimura J., Shima T., Umesaki Y., Yamamoto M., Onoue M., et al. ATP drives lamina propria TH17 cell differentiation. Nature 2008, 455:808-812.
51. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(Suppl. 1):4615-4622.
52. Berer K., Mues M., Koutrolos M., Rasbi Z.A., Boziki M., Johner C., et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011, 479:538-541.
53. Junger W.G., Liu F.C., Loomis W.H., Hoyt D.B. Hypertonic saline enhances cellular immune function. Circulatory Shock 1994, 42:190-196.
54. Go W.Y., Liu X., Roti M.A., Liu F., Ho S.N. NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:10673-10678.
55. Machnik A., Neuhofer W., Jantsch J., Dahlmann A., Tammela T., Machura K., et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nature Medicine 2009, 15:545-552.
56. Wiig H., Schroder A., Neuhofer W., Jantsch J., Kopp C., Karlsen T.V., et al. Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. Journal of Clinical Investigation 2013, 123:2803-2815.
57. Machnik A., Dahlmann A., Kopp C., Goss J., Wagner H., van Rooijen N., et al. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats. Hypertension 2010, 55:755-761.
58. Kleinewietfeld M., Manzel A., Titze J., Kvakan H., Yosef N., Linker R.A., et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013, 496:518-522.
59. Wu C., Yosef N., Thalhamer T., Zhu C., Xiao S., Kishi Y., et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013, 496:513-517.
60. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunological Reviews 2006, 212:28-50.
61. Sakaguchi S., Miyara M., Costantino C.M., Hafler D.A. FOXP3+ regulatory T cells in the human immune system. Nature Reviews Immunology 2010, 10:490-500.
62. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25 high regulatory cells in human peripheral blood. Journal of Immunology 2001, 167:1245-1253.
63. Fontenot J.D., Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nature Immunology 2005, 6:331-337.
64. Baron U., Floess S., Wieczorek G., Baumann K., Grutzkau A., Dong J., et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. European Journal of Immunology 2007, 37:2378-2389.
65. Ohkura N., Kitagawa Y., Sakaguchi S. Development and maintenance of regulatory T cells. Immunity 2013, 38:414-423.
66. Randolph D.A., Fathman C.G. Cd4+Cd25+ regulatory T cells and their therapeutic potential. Annual Review of Medicine 2006, 57:381-402.
67. Vignali D.A.A., Collison L.W., Workman C.J. How regulatory T cells work. Nature Reviews Immunology 2008, 8:523-532.
68. Tang Q.Z., Bluestone J.A. The Foxp3(+) regulatory T cell: a jack of all trades, master of regulation. Nature Immunology 2008, 9:239-244.
69. Bach J.F. Regulatory T cells under scrutiny. Nature Reviews Immunology 2003, 3:189-198.
70. Horwitz D.A., Zheng S.G., Gray J.D. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends in Immunology 2008, 29:429-435.
71. Zheng Y., Rudensky A.Y. Foxp3 in control of the regulatory T cell lineage. Nature Immunology 2007, 8:457-462.
72. Kleinewietfeld M., Puentes F., Borsellino G., Battistini L., Rotzschke O., Falk K. CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. Blood 2005, 105:2877-2886.
73. Borsellino G., Kleinewietfeld M., Di Mitri D., Sternjak A., Diamantini A., Giometto R., et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007, 110:1225-1232.
74. Baecher-Allan C., Wolf E., Hafler D.A. MHC class II expression identifies functionally distinct human regulatory T cells. Journal of Immunology 2006, 176:4622-4631.
75. Haas J., Fritzsching B., Trubswetter P., Korporal M., Milkova L., Fritz B., et al. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. Journal of Immunology 2007, 179:1322-1330.
76. Fritzsching B., Oberle N., Pauly E., Geffers R., Buer J., Poschl J., et al. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 2006, 108:3371-3378.
77. Solstad T., Bains S.J., Landskron J., Aandahl E.M., Thiede B., Tasken K., et al. CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells. Blood 2011, 118:5141-5151.
78. Ito T., Hanabuchi S., Wang Y.H., Park W.R., Arima K., Bover L., et al. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 2008, 28:870-880.
79. Huehn J., Siegmund K., Hamann A. Migration rules: functional properties of naive and effector/memory-like regulatory T cell subsets. Current Topics in Microbiology and Immunology 2005, 293:89-114.
80. Huehn J., Hamann A. Homing to suppress: address codes for Treg migration. Trends in Immunology 2005, 26:632-636.
81. Rosenblum M.D., Gratz I.K., Paw J.S., Lee K., Marshak-Rothstein A., Abbas A.K. Response to self antigen imprints regulatory memory in tissues. Nature 2011, 480:538-542.
82. Gratz I.K., Rosenblum M.D., Abbas A.K. The life of regulatory T cells. Annals of the New York Academy of Sciences 2013, 1283:8-12.
83. Apostolou I., von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. Journal of Experimental Medicine 2004, 199:1401-1408.
84. Ling E.M., Smith T., Nguyen X.D., Pridgeon C., Dallman M., Arbery J., et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004, 363:608-615.
85. Baecher-Allan C., Hafler D.A. Human regulatory T cells and their role in autoimmune disease. Immunological Reviews 2006, 212:203-216.
86. + regulatory T cells in patients with multiple sclerosis. Journal of Experimental Medicine 2004, 199:971-979.
87. +CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. European Journal of Immunology 2005, 35:3343-3352.
88. + regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. Journal of Immunology 2009, 183:7602-7610.
89. De Jager P.L., Baecher-Allan C., Maier L.M., Arthur A.T., Ottoboni L., Barcellos L., et al. The role of the CD58 locus in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:5264-5269.
90. +CD25(hi) regulatory cells in patients with multiple sclerosis. Journal of Immunology 2011, 186:3317-3326.
91. Lowther D.E., Hafler D.A. Regulatory T cells in the central nervous system. Immunological Reviews 2012, 248:156-169.
92. Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.
93. + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:12204-12209.
94. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
95. Ochoa-Reparaz J., Mielcarz D.W., Wang Y., Begum-Haque S., Dasgupta S., Kasper D.L., et al. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunology 2010, 3:487-495.
96. Ochoa-Reparaz J., Mielcarz D.W., Ditrio L.E., Burroughs A.R., Begum-Haque S., Dasgupta S., et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. Journal of Immunology 2010, 185:4101-4108.
97. Atarashi K., Tanoue T., Oshima K., Suda W., Nagano Y., Nishikawa H., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013, 500:232-236.
98. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
99. Du J., Huang C., Zhou B., Ziegler S.F. Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. Journal of Immunology 2008, 180:4785-4792.
100. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317:256-260.
101. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
102. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
103. Dang E.V., Barbi J., Yang H.Y., Jinasena D., Yu H., Zheng Y., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011, 146:772-784.
104. Shi L.Z., Wang R., Huang G., Vogel P., Neale G., Green D.R., et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. Journal of Experimental Medicine 2011, 208:1367-1376.
105. Tsun A., Chen Z., Li B. Romance of the three kingdoms: RORgammat allies with HIF1alpha against FoxP3 in regulating T cell metabolism and differentiation. Protein & Cell 2011, 2:778-781.
106. Poutahidis T., Kleinewietfeld M., Smillie C., Levkovich T., Perrotta A., Bhela S., et al. Microbial reprogramming inhibits Western diet-associated obesity. PLOS ONE 2013, 8:e68596.
107. Harrington L.E., Mangan P.R., Weaver C.T. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Current Opinion in Immunology 2006, 18:349-356.
108. Lee Y.K., Turner H., Maynard C.L., Oliver J.R., Chen D., Elson C.O., et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92-107.
109. + T cells. Immunity 2009, 30:155-167.
110. Hirota K., Duarte J.H., Veldhoen M., Hornsby E., Li Y., Cua D.J., et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nature Immunology 2011, 12:255-263.
111. Annunziato F., Cosmi L., Liotta F., Maggi E., Romagnani S. Defining the human T helper 17 cell phenotype. Trends in Immunology 2012, 33:505-512.
112. Maggi L., Santarlasci V., Capone M., Rossi M.C., Querci V., Mazzoni A., et al. Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells. European Journal of Immunology 2012, 42:3180-3188.
113. Ghoreschi K., Laurence A., Yang X.P., Tato C.M., McGeachy M.J., Konkel J.E., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010, 467:967-971.
114. Lee Y., Awasthi A., Yosef N., Quintana F.J., Xiao S., Peters A., et al. Induction and molecular signature of pathogenic TH17 cells. Nature Immunology 2012, 13:991-999.
115. Zielinski C.E., Mele F., Aschenbrenner D., Jarrossay D., Ronchi F., Gattorno M., et al. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 2012, 484:514-518.
116. Esplugues E., Huber S., Gagliani N., Hauser A.E., Town T., Wan Y.Y., et al. Control of TH17 cells occurs in the small intestine. Nature 2011, 475:514-518.
117. Panzer M., Sitte S., Wirth S., Drexler I., Sparwasser T., Voehringer D. Rapid in vivo conversion of effector T cells into Th2 cells during helminth infection. Journal of Immunology 2012, 188:615-623.
118. Hirahara K., Poholek A., Vahedi G., Laurence A., Kanno Y., Milner J.D., et al. Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease. Journal of allergy and clinical immunology 2013, 131:1276-1287.
119. Zhou X., Bailey-Bucktrout S., Jeker L.T., Bluestone J.A. Plasticity of CD4(+) FoxP3(+) T cells. Current Opinion in Immunology 2009, 21:281-285.
120. Stock P., Akbari O., Berry G., Freeman G.J., Dekruyff R.H., Umetsu D.T. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nature Immunology 2004, 5:1149-1156.
121. Wan Y.Y., Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007, 445:766-770.
122. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nature Immunology 2007, 8:277-284.
123. Duarte J.H., Zelenay S., Bergman M.L., Martins A.C., Demengeot J. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. European Journal of Immunology 2009, 39:948-955.
124. Zhou X., Bailey-Bucktrout S.L., Jeker L.T., Penaranda C., Martinez-Llordella M., Ashby M., et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nature Immunology 2009, 10:1000-1007.
125. Oldenhove G., Bouladoux N., Wohlfert E.A., Hall J.A., Chou D., Dos Santos L., et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009, 31:772-786.
126. + T cells that inhibit colitis. Gastroenterology 2011, 140:2031-2043.
127. Dieckmann D., Plottner H., Berchtold S., Berger T., Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. Journal of Experimental Medicine 2001, 193:1303-1310.
128. + regulatory T cells upon repetitive in vitro stimulation. European Journal of Immunology 2009, 39:1088-1097.
129. +CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006, 108:4260-4267.
130. Gavin M.A., Torgerson T.R., Houston E., DeRoos P., Ho W.Y., Stray-Pedersen A., et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:6659-6664.
131. + regulatory T cells in human autoimmune disease. Nature Medicine 2011, 17:673-675.
132. McClymont S.A., Putnam A.L., Lee M.R., Esensten J.H., Liu W., Hulme M.A., et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. Journal of Immunology 2011, 186:3918-3926.
133. - T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. Journal of Immunology 2007, 178:6725-6729.
134. Koenen H.J., Smeets R.L., Vink P.M., van Rijssen E., Boots A.M., Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008, 112:2340-2352.
135. Osorio F., LeibundGut-Landmann S., Lochner M., Lahl K., Sparwasser T., Eberl G., et al. DC activated via dectin-1 convert Treg into IL-17 producers. European Journal of Immunology 2008, 38:3274-3281.
136. Yang X.O., Nurieva R., Martinez G.J., Kang H.S., Chung Y., Pappu B.P., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008, 29:44-56.
137. Li L., Patsoukis N., Petkova V., Boussiotis V.A. Runx1 and Runx3 are involved in the generation and function of highly suppressive IL-17-producing T regulatory cells. PLoS ONE 2012, 7:e45115.
138. Beriou G., Costantino C.M., Ashley C.W., Yang L., Kuchroo V.K., Baecher-Allan C., et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009, 113:4240-4249.
139. Voo K.S., Wang Y.H., Santori F.R., Boggiano C., Wang Y.H., Arima K., et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:4793-4798.
140. + Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:8635-8640.
141. Nyirenda M.H., Sanvito L., Darlington P.J., O'Brien K., Zhang G.X., Constantinescu C.S., et al. TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function. Journal of Immunology 2011, 187:2278-2290.
142. + regulatory T cells into proinflammatory interleukin 17-producing helper T cells. Journal of Immunotherapy 2009, 32:101-108.
143. Sharma M.D., Hou D.Y., Liu Y., Koni P.A., Metz R., Chandler P., et al. Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 2009, 113:6102-6111.
144. Kleinewietfeld M., DiMitri D., Sternjak A., Diamantini A., Borsellino G., Battistini L., et al. Hydrolysis of extracellular ATP by CD39(+) Treg cells: context matters!. Blood 2008, 111:965-966.
145. Mascanfroni I.D., Yeste A., Vieira S.M., Burns E.J., Patel B., Sloma I., et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nature Immunology 2013.
146. Bovenschen H.J., van de Kerkhof P.C., van Erp P.E., Woestenenk R., Joosten I., Koenen H.J. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. Journal of Investigative Dermatology 2011, 131:1853-1860.
147. Singh K., Gatzka M., Peters T., Borkner L., Hainzl A., Wang H., et al. Reduced CD18 levels drive regulatory T cell conversion into Th17 cells in the CD18hypo PL/J mouse model of psoriasis. Journal of Immunology 2013, 190:2544-2553.
148. Longhi M.S., Liberal R., Holder B., Robson S.C., Ma Y., Mieli-Vergani G., et al. Inhibition of interleukin-17 promotes differentiation of CD25(-) cells into stable T regulatory cells in patients with autoimmune hepatitis. Gastroenterology. 2012, 142:1526-1535. e1526.
149. Muratori L., Longhi M.S. The interplay between regulatory and effector T cells in autoimmune hepatitis: implications for innovative treatment strategies. Journal of Autoimmunity 2013.
150. Liu X., Gao N., Li M., Xu D., Hou Y., Wang Q., et al. Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction. PLOS ONE 2013, 8:e64531.